Pentraxin 3 in the cerebrospinal fluid during central nervous system infections: A retrospective cohort study

Martin Munthe Thomsen, Lea Munthe-Fog, Pelle Trier Petersen, Thore Hillig, Lennart Jan Friis-Hansen, Casper Roed, Zitta Barrella Harboe, Christian Thomas Brandt

Abstract

The present study describes diagnostic and prognostic abilities of Cerebrospinal fluid (CSF) Pentraxin 3 (PTX3) in central nervous system (CNS) infections. CSF PTX3 was measured retrospectively from 174 patients admitted under suspicion of CNS infection. Medians, ROC curves and Youdens index was calculated. CSF PTX3 was significantly higher among all CNS infections and undetectable in most of the patients in the control group, and significantly higher in bacterial infections compared to viral and Lyme infections. No association was found between CSF PTX3 and Glasgow Outcome Score. PTX3 in the CSF can distinguish bacterial infection from viral and Lyme infections and non-CNS infections. Highest levels were found in bacterial meningitis. No prognostic abilities were found.

Original languageEnglish
Article numbere0282004
JournalPLoS One
Volume18
Issue number3
Pages (from-to)e0282004
ISSN1932-6203
DOIs
Publication statusPublished - 2023

Fingerprint

Dive into the research topics of 'Pentraxin 3 in the cerebrospinal fluid during central nervous system infections: A retrospective cohort study'. Together they form a unique fingerprint.

Cite this